Concepedia

Marta Carretero

MC

Statistics

Publications

41

Citations

3.7K

H-Index

25

Active since

1993

Affiliations

Hospital Universitario de La Princesa(Current)

Centre for Biomedical Network Research on Rare Diseases

Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas

Universidad Autónoma de Madrid

Hospital Universitario Fundación Jiménez Díaz

Marta Carretero is an author at Hospital Universitario de La Princesa specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1993–2022

41

Publications

41

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

Ni Lee, Manuel Llano, Marta Carretero et al. · Proceedings of the National Academy of Sciences · 1998 · 1K citations · Full text

, , +14

In vitro and In vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37

Marta Carretero, M.J. Escámez, Marta García et al. · Journal of Investigative Dermatology · 2007 · 339 citations · Full text

, , +5

The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules

Marta Carretero, Claudia Cantoni, Teresa Bellón et al. · European Journal of Immunology · 1997 · 275 citations

Molecular characterization of human CD94: A type II membrane glycoprotein related to the C‐type lectin superfamily

Chiwen Chang, Antonio Rodrı́guez, Marta Carretero et al. · European Journal of Immunology · 1995 · 206 citations

The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1

Juan J. Pérez‐Villar, Ignacio Melero, Francisco Navarro et al. · The Journal of Immunology · 1997 · 154 citations · Full text

1–5 of 41